Bipyridines useful for the treatment of proliferative diseases

Details for Australian Patent Application No. 2010291206 (hide)

Owner Novartis AG

Inventors Barsanti, Paul A.; Hu, Cheng; Jin, Xianming; Ng, Simon C.; Pfister, Keith B.; Sendzik, Martin; Sutton, James

Agent Davies Collison Cave

Pub. Number AU-A-2010291206

PCT Pub. Number WO2011/026911

Priority 61/275,938 04.09.09 US; 61/284,961 28.12.09 US

Filing date 2 September 2010

Wipo publication date 10 March 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/026911 Priority application(s): WO2011/026911

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010291208-Polypeptides having oxidoreductase activity and their uses

2010291203-An auditory test and compensation method